Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento (I). Enfermedad del hígado graso no alcohólico y su asociación con la enfermedad cardiovascular
- Brea, Ángel
- Pintó, Xavier
- Ascaso, Juan F.
- Blasco, Mariano
- Díaz, Ángel
- González-Santos, Pedro
- Hernández Mijares, Antonio
- Mantilla, Teresa
- Millán, Jesús
- Pedro-Botet, Juan
ISSN: 0214-9168, 1578-1879
Year of publication: 2017
Volume: 29
Issue: 3
Pages: 141-148
Type: Article
More publications in: Clínica e investigación en arteriosclerosis
Abstract
Non-alcoholic fatty liver disease (NAFLD) comprises a series of histologically lesions similar to those induced by alcohol consumption in people with very little or no liver damage. The importance of NAFLD is its high prevalence in the Western world and, from the point of view of the liver, in its gradual progression from steatosis to steatohepatitis, cirrhosis, and liver cancer. During the last decade it has been observed that NAFLD leads to an increased cardiovascular risk with acceleration of arteriosclerosis and events related to it, being the main cause of its morbidity and mortality. This review, updated to January 2016, consists of two parts, with the first part analysing the association of NAFLD with cardiovascular disease.